Ethyl (1S,2R)-2-aminocyclopentane-1-carboxylate hydrochloride, 95%, 1g

7-Methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one, 95.0%, 25g

4-(Phenylmethylidene)-1,2,3,4-tetrahydroacridine-9-carboxylic acid, 95%, 250mg

1-[3-(Trifluoromethyl)phenyl]-1H-imidazole-4-carboxylic acid, 100mg

N-[3-(Triethoxysilyl)propyl]-4,5-dihydroimidazole, 99%, 5g

3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid, 95.0%, 500mg

8-bromo-2-methyl-4-quinolinol, 95.0%, 5g

6-(4-((5-CHLORO-4-((4-CHLOROPHENYL)AMINO)PYRIMIDIN-2-YL)AMINO)-1H-PYRAZOL-1-YL)-N-HYDROXYHEXANAMIDE, 95%, 5mg

Sulfato de sodio anhidro 99,9+% 50 g

5-Borono-1-naphthoic acid, 95.0%, 250mg

m-cresol, mínimo 99 %, para síntesis, 250 ml, envase de vidrio

3-(4-tert-butylphenyl)-3-hydroxy-1-(4-methoxyphenyl)prop-2-en-1-one, 97%, 500g

Nonafluorohexyltrimethoxysilane, 95%, 100g